Androgen receptor variant shows heterogeneous expression in prostate cancer according to differentiation stage

Quantitation of androgen receptor variant (AR-V) expression in circulating tumor cells (CTCs) from patients with metastatic castration-resistant prostate cancer (mCRPC) has great potential for treatment customization. However, the absence of a uniform CTC isolation platform and consensus on an analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Gjyrezi, Ada, Galletti, Giuseppe, Zhang, Jiaren, Worroll, Daniel, Sigouros, Michael, Kim, Seaho, Cooley, Victoria, Ballman, Karla V., Ocean, Allyson J., Shah, Manish A., Scandura, Joseph M., Sboner, Andrea, Nanus, David M., Beltran, Himisha, Tagawa, Scott, Giannakakou, Paraskevi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225618/
https://www.ncbi.nlm.nih.gov/pubmed/34168263
http://dx.doi.org/10.1038/s42003-021-02321-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225618/
https://www.ncbi.nlm.nih.gov/pubmed/34168263
http://dx.doi.org/10.1038/s42003-021-02321-9

Ejemplares similares